Carboxyl-substituted glucocorticoid receptor agonists
The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof: # imgabs0 # wherein R1 is H, halogen, a C1-C3 alkyl group, or a C1-C3 alkoxy group; r2 is H or halogen; and X is O, OCH2 or CH2; wherein the compound of formula I or a pharmaceutically acceptable sa...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | WURSTER JOHN M STITES RYAN EDWARD |
description | The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof: # imgabs0 # wherein R1 is H, halogen, a C1-C3 alkyl group, or a C1-C3 alkoxy group; r2 is H or halogen; and X is O, OCH2 or CH2; wherein the compound of formula I or a pharmaceutically acceptable salt thereof is useful in the treatment of autoimmune and inflammatory diseases, such as atopic dermatitis, rheumatoid arthritis and lupus nephritis.
本发明提供了式I的化合物或其可药用盐:#imgabs0#其中R1是H、卤素、C1-C3烷基或C1-C3烷氧基;R2是H或卤素;且X是是O、OCH2或CH2;其中所述式I的化合物或其可药用盐用于治疗自身免疫性疾病和炎性疾病,例如特应性皮炎、类风湿性关节炎和狼疮肾炎。 |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN116888137A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN116888137A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN116888137A3</originalsourceid><addsrcrecordid>eNrjZDB1TixKyq-ozNEtLk0qLsksKS1JTVFIzylNzk_OLyrJTM7PTFEoSk1OLSjJL1JITM_PyywuKeZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfHOfoaGZhYWFobG5o7GxKgBAO9TLmk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Carboxyl-substituted glucocorticoid receptor agonists</title><source>esp@cenet</source><creator>WURSTER JOHN M ; STITES RYAN EDWARD</creator><creatorcontrib>WURSTER JOHN M ; STITES RYAN EDWARD</creatorcontrib><description>The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof: # imgabs0 # wherein R1 is H, halogen, a C1-C3 alkyl group, or a C1-C3 alkoxy group; r2 is H or halogen; and X is O, OCH2 or CH2; wherein the compound of formula I or a pharmaceutically acceptable salt thereof is useful in the treatment of autoimmune and inflammatory diseases, such as atopic dermatitis, rheumatoid arthritis and lupus nephritis.
本发明提供了式I的化合物或其可药用盐:#imgabs0#其中R1是H、卤素、C1-C3烷基或C1-C3烷氧基;R2是H或卤素;且X是是O、OCH2或CH2;其中所述式I的化合物或其可药用盐用于治疗自身免疫性疾病和炎性疾病,例如特应性皮炎、类风湿性关节炎和狼疮肾炎。</description><language>chi ; eng</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; STEROIDS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231013&DB=EPODOC&CC=CN&NR=116888137A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76419</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231013&DB=EPODOC&CC=CN&NR=116888137A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WURSTER JOHN M</creatorcontrib><creatorcontrib>STITES RYAN EDWARD</creatorcontrib><title>Carboxyl-substituted glucocorticoid receptor agonists</title><description>The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof: # imgabs0 # wherein R1 is H, halogen, a C1-C3 alkyl group, or a C1-C3 alkoxy group; r2 is H or halogen; and X is O, OCH2 or CH2; wherein the compound of formula I or a pharmaceutically acceptable salt thereof is useful in the treatment of autoimmune and inflammatory diseases, such as atopic dermatitis, rheumatoid arthritis and lupus nephritis.
本发明提供了式I的化合物或其可药用盐:#imgabs0#其中R1是H、卤素、C1-C3烷基或C1-C3烷氧基;R2是H或卤素;且X是是O、OCH2或CH2;其中所述式I的化合物或其可药用盐用于治疗自身免疫性疾病和炎性疾病,例如特应性皮炎、类风湿性关节炎和狼疮肾炎。</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>STEROIDS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDB1TixKyq-ozNEtLk0qLsksKS1JTVFIzylNzk_OLyrJTM7PTFEoSk1OLSjJL1JITM_PyywuKeZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfHOfoaGZhYWFobG5o7GxKgBAO9TLmk</recordid><startdate>20231013</startdate><enddate>20231013</enddate><creator>WURSTER JOHN M</creator><creator>STITES RYAN EDWARD</creator><scope>EVB</scope></search><sort><creationdate>20231013</creationdate><title>Carboxyl-substituted glucocorticoid receptor agonists</title><author>WURSTER JOHN M ; STITES RYAN EDWARD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN116888137A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>STEROIDS</topic><toplevel>online_resources</toplevel><creatorcontrib>WURSTER JOHN M</creatorcontrib><creatorcontrib>STITES RYAN EDWARD</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WURSTER JOHN M</au><au>STITES RYAN EDWARD</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Carboxyl-substituted glucocorticoid receptor agonists</title><date>2023-10-13</date><risdate>2023</risdate><abstract>The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof: # imgabs0 # wherein R1 is H, halogen, a C1-C3 alkyl group, or a C1-C3 alkoxy group; r2 is H or halogen; and X is O, OCH2 or CH2; wherein the compound of formula I or a pharmaceutically acceptable salt thereof is useful in the treatment of autoimmune and inflammatory diseases, such as atopic dermatitis, rheumatoid arthritis and lupus nephritis.
本发明提供了式I的化合物或其可药用盐:#imgabs0#其中R1是H、卤素、C1-C3烷基或C1-C3烷氧基;R2是H或卤素;且X是是O、OCH2或CH2;其中所述式I的化合物或其可药用盐用于治疗自身免疫性疾病和炎性疾病,例如特应性皮炎、类风湿性关节炎和狼疮肾炎。</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | chi ; eng |
recordid | cdi_epo_espacenet_CN116888137A |
source | esp@cenet |
subjects | CHEMISTRY METALLURGY ORGANIC CHEMISTRY STEROIDS |
title | Carboxyl-substituted glucocorticoid receptor agonists |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T16%3A06%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WURSTER%20JOHN%20M&rft.date=2023-10-13&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN116888137A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |